WHO has declared the upsurge of mpox in the DRC and other African countries as a public health emergency of international concern, citing its potential
People with disabilities are largely excluded from clinical trials that could benefit them because federal agencies have failed to update rules that govern how trials
A widespread, monthslong contract dispute between UnitedHealthcare and Trinity Health has created a confusing patchwork of disrupted access across multiple states. UnitedHealthcare is the country’s
WASHINGTON — The White House is touting just how much its new Medicare negotiation process cut drug prices. The problem is, the numbers it’s using
Lykos Therapeutics, whose MDMA-assisted psychotherapy for post-traumatic stress disorder was rejected late last week by U.S. regulators, announced Thursday that it would cut 75% of
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and culture. Subscribe AnnuallySubscribe Monthly Already
What You Should Know: – Medable Inc., the leading technology platform for clinical trials, today announced Medable Studio, an all-in-one application for configuring, translating, validating,
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Stereotaxis has secured Europe’s CE
Dive Brief: Tandem Diabetes Care warned that some people are still experiencing problems with an iPhone app rapidly depleting their insulin pump battery, despite a